Optimization of efficiency and energy saving in public lighting with multi-objective  evolutionary algorithms

Lorente, D. Gómez; Rabaza, O.; Espín, Antonio M.; García, A. Peña

doi:10.24084/repqj11.215

Cited by 9 publications

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In cardiovascular patients, Febuxostat for treating gout is indicated if the patient is contraindicated for allopurinol or if allopurinol is not effective. Febuxostat has greater risk for cardiovascular death than allopurinol [14] .…”

Section: Cardiovascular Diseasementioning

confidence: 96%

Risk for death increasing with cardiovascular chronic gout patients associated with febuxostat

Ramachandran¹,

Yadav²,

Devkota³

2020

ijrls

View full text Add to dashboard Cite

Febuxostat used for the treatment of patients with arthritis littered with Hyperuricemia and is utilized in its Chronic Management. a number of the internal organ adverse effects have diode to the employment of febuxostat replaced with with allopurinol drug. Febuxostat, associate degree compound accelerator matter, achieves its therapeutic result by decreasing humour acid. At therapeutic concentrations it is not expected that Febuxostat will inhibit different enzymes which are involved in purine and pyrimidine synthesis and their metabolism. Metabolism of Febuxostat is done by conjugation via uridine diphosphate glucuronosyltransferase (UGT) enzymes and also by UGT1A1, UGT1A3, UGT1A9, and UGT2B7 and reaction via hemoprotein P450 (CYP) enzymes as well as CYP1A2, 2C8 and 2C9 and non-P450 enzymes. Febuxostat is eliminated primarily through each viscus and excretory organ pathways. Febuxostat could cause heart issues that may result in coronary failure, could cause issues within the blood vessels that visit your brain. this could conjointly result in stroke, urarthritis flare-ups and Liver injury. Some facet effects of febuxostat could occur that sometimes don't would like medical attention. We conclude from our review, vessel Death urarthritis patients with established vessel (CV) illness treated with febuxostat had a better rate of CV death compared to those treated with allopurinol drug in a very CV outcomes study.

show abstract

Section: Cardiovascular Diseasementioning

confidence: 96%

Risk for death increasing with cardiovascular chronic gout patients associated with febuxostat

Ramachandran¹,

Yadav²,

Devkota³

2020

ijrls

View full text Add to dashboard Cite

show abstract

Multiobjective energy efficient street lighting framework: A data analysis approach

2022

View full text Add to dashboard Cite

ANNEGA: an artificial neural network embedded genetic algorithm approach for energy efficient street lighting

Sikdar,

Kar,

Thakurta

2024

Evol. Intel.

View full text Add to dashboard Cite

Optimization of efficiency and energy saving in public lighting with multi-objective evolutionary algorithms

Abstract: Abstract. Multi-objective evolutionary algorithms have been applied to classical problems in public lighting calculations with the aim of finding the most optimal solutions among the very large set of different configurations achieved with the standard methods.

Cited by 9 publications

References 2 publications

Risk for death increasing with cardiovascular chronic gout patients associated with febuxostat

Risk for death increasing with cardiovascular chronic gout patients associated with febuxostat

Multiobjective energy efficient street lighting framework: A data analysis approach

ANNEGA: an artificial neural network embedded genetic algorithm approach for energy efficient street lighting

Contact Info

Product

Resources

About